|
1
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Miller AJ and Mihm MC Jr: Melanoma. N Engl
J Med. 355:51–65. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gray-Schopfer V, Wellbrock C and Marais R:
Melanoma biology and new targeted therapy. Nature. 445:851–857.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
John B, Enright AJ, Aravin A, Tuschl T,
Sander C and Marks DS: Human MicroRNA targets. PLoS Biol.
2:e3632004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Nishikawa S, Ishii H, Haraguchi N, Kano Y,
Fukusumi T, Ohta K, Ozaki M, Dewi DL, Sakai D, Satoh T, et al:
microRNA-based cancer cell reprogramming technology. Exp Ther Med.
4:8–14. 2012.PubMed/NCBI
|
|
7
|
Ha M and Kim VN: Regulation of microRNA
biogenesis. Nat Rev Mol Cell Biol. 15:509–524. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gerin I, Clerbaux LA, Haumont O, Lanthier
N, Das AK, Burant CF, Leclercq IA, MacDougald OA and Bommer GT:
Expression of miR-33 from an SREBP2 intron inhibits cholesterol
export and fatty acid oxidation. J Biol Chem. 285:33652–33661.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Marquart TJ, Allen RM, Ory DS and Baldán
A: miR-33 links SREBP-2 induction to repression of sterol
transporters. Proc Natl Acad Sci USA. 107:12228–12232. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Najafi-Shoushtari SH, Kristo F, Li Y,
Shioda T, Cohen DE, Gerszten RE and Näär AM: MicroRNA-33 and the
SREBP host genes cooperate to control cholesterol homeostasis.
Science. 328:1566–1569. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dávalos A, Goedeke L, Smibert P, Ramírez
CM, Warrier NP, Andreo U, Cirera-Salinas D, Rayner K, Suresh U,
Pastor-Pareja JC, et al: miR-33a/b contribute to the regulation of
fatty acid metabolism and insulin signaling. Proc Natl Acad Sci
USA. 108:9232–9237. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cirera-Salinas D, Pauta M, Allen RM,
Salerno AG, Ramírez CM, Chamorro-Jorganes A, Wanschel AC, Lasuncion
MA, Morales-Ruiz M, Suarez Y, et al: Mir-33 regulates cell
proliferation and cell cycle progression. Cell Cycle. 11:922–933.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Takwi AA and Li Y, Buscaglia Becker LE,
Zhang J, Choudhury S, Park AK, Liu M, Young KH, Park WY, Martin RC
and Li Y: A statin-regulated microRNA represses human c-Myc
expression and function. EMBO Mol Med. 4:896–909. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Thomas M, Lange-Grünweller K, Weirauch U,
Gutsch D, Aigner A, Grünweller A and Hartmann RK: The
proto-oncogene Pim-1 is a target of miR-33a. Oncogene. 31:918–928.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Rice SJ, Lai SC, Wood LW, Helsley KR,
Runkle EA, Winslow MM and Mu D: MicroRNA-33a mediates the
regulation of high mobility group AT-hook 2 gene (HMGA2) by thyroid
transcription factor 1 (TTF-1/NKX2-1). J Biol Chem.
288:16348–16360. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Meyerson M, Enders GH, Wu CL, Su LK, Gorka
C, Nelson C, Harlow E and Tsai LH: A family of human cdc2-related
protein kinases. EMBO J. 11:2909–2917. 1992.PubMed/NCBI
|
|
17
|
Okuda T, Cleveland JL and Downing JR:
PCTAIRE-1 and PCTAIRE-3, two members of a novel cdc2/CDC28-related
protein kinase gene family. Oncogene. 7:2249–2258. 1992.PubMed/NCBI
|
|
18
|
Yeung ML, Houzet L, Yedavalli VS and Jeang
KT: A genome-wide short hairpin RNA screening of jurkat T-cells for
human proteins contributing to productive HIV-1 replication. J Biol
Chem. 284:19463–19473. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Fu WY, Cheng K, Fu AK and Ip NY:
Cyclin-dependent kinase 5-dependent phosphorylation of Pctaire1
regulates dendrite development. Neuroscience. 180:353–359. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen XY, Gu XT, Saiyin H, Wan B, Zhang YJ,
Li J, Wang YL, Gao R, Wang YF, Dong WP, et al: Brain-selective
kinase 2 (BRSK2) phosphorylation on PCTAIRE1 negatively regulates
glucose-stimulated insulin secretion in pancreatic β-cells. J Biol
Chem. 287:30368–30375. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hill SJ, Rolland T, Adelmant G, Xia X,
Owen MS, Dricot A, Zack TI, Sahni N, Jacob Y, Hao T, et al:
Systematic screening reveals a role for BRCA1 in the response to
transcription-associated DNA damage. Genes Dev. 28:1957–1975. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yanagi T, Krajewska M, Matsuzawa S and
Reed JC: PCTAIRE1 phosphorylates p27 and regulates mitosis in
cancer cells. Cancer Res. 74:5795–5807. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cai Y, Yu X, Hu S and Yu J: A brief review
on the mechanisms of miRNA regulation. Genomics Proteomics
Bioinformatics. 7:147–154. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chu IM, Hengst L and Slingerland JM: The
Cdk inhibitor p27 in human cancer: Prognostic potential and
relevance to anticancer therapy. Nat Rev Cancer. 8:253–267. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Palmer KJ, Konkel JE and Stephens DJ:
PCTAIRE protein kinases interact directly with the COPII complex
and modulate secretory cargo transport. J Cell Sci. 118:3839–3847.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Vervoorts J and Lüscher B:
Post-translational regulation of the tumor suppressor p27(KIP1).
Cell Mol Life Sci. 65:3255–3264. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lee SR, Shin JW, Kim HO, Son BH, Yoo CH
and Shin JH: Determining the effect of transforming growth
factor-β1 on cdk4 and p27 in gastric cancer and cholangiocarcinoma.
Oncol Lett. 5:694–698. 2013.PubMed/NCBI
|
|
29
|
Zhang M, Li J, Wang L, Tian Z, Zhang P, Xu
Q, Zhang C, Wei F and Chen W: Prognostic significance of p21, p27
and survivin protein expression in patients with oral squamous cell
carcinoma. Oncol Lett. 6:381–386. 2013.PubMed/NCBI
|
